Navigation Links
Trius Doses First Patient in Antibacterial Phase 2 Trial
Date:9/21/2008

TR-701 Tested for Efficacy in Drug Resistant Skin Infections

SAN DIEGO, Sept. 22 /PRNewswire/ -- Trius Therapeutics, Inc. today announced the initiation of Phase 2 testing of the oral form of its second-generation oxazolidinone antibacterial drug TR-701. The multicenter trial will test the efficacy, safety and tolerability of once-daily doses of 200, 300 and 400 milligrams of TR-701 in complicated skin and skin structure infections (cSSSI) for five to seven days of treatment.

The study follows the recently completed two-part Phase 1 study that tested the safety, tolerability and pharmacokinetics of TR-701 in single and multiple ascending doses for up to 21 days compared with Zyvox(R) (linezolid), the only marketed drug of the oxazolidinone class. In addition, separate food effect and microdialysis studies measuring the absorption of TR-701 in the presence and absence of food and the tissue penetration of the drug, respectively, have also been completed.

Results of the Phase 1 trials will be presented at the joint annual meetings of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Diseases Society of America (IDSA) in Washington, D.C in October 2008.

"Our Phase 1 study results indicate that TR-701 will be a once-daily drug with the potential to offer patients several important advantages over linezolid as well as other marketed drugs," said Philippe Prokocimer, M.D., Chief Medical Officer of Trius. "The intent of Phase 2 will be to validate these observations in a patient population and to select a therapeutic dosing regimen from the three doses being tested."

"The growing epidemic of MRSA in the hospital and community leaves few viable treatment options for patients requiring an oral drug," said Jeffrey Stein, Ph.D., Chief Executive Officer of Trius. "We believe that the once-daily dosing and short course of TR-701 therapy of five to seven days will offer a clinical advantage fo
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. PacificGMP Completes GMP Product Fill for Trius Therapeutics
2. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
5. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
6. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
7. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
8. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
9. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
10. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
11. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., CHICAGO, Nov. 30 Minimally-inva...stly open surgery, particularly in oncology, cardi...bal market for image-guided navigation expected to...ing the advantages offered by minimally-invasive p...s, greater patient comfort and faster patient thro...
(Date:11/30/2009)..., BEIJING, Nov. 30 /PRNewswire-Asia-FirstCall/...d: LTUS) ("Lotus" or the "Company") a growing deve...sed national seller of pharmaceutical,products in ...rted that its,Over-the-Counter Drug division ("OTC...acts with more than five hundred drug stores in Be...
(Date:11/30/2009)... THOUSAND OAKS, Calif., Nov. 30 /PRNewswire-FirstC...d that it will present updated long-term safety an...adult chronic immune (idiopathic) thrombocytopenic...he first Nplate study in a pediatric setting as we...MDS) at the 2009 American Society of Hematology (A...
Breaking Medicine Technology:Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 2Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 3Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 1Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 2Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 3Microscopic beads could help create designer immune cells that ignore transplanted organs 50768 1Microscopic beads could help create designer immune cells that ignore transplanted organs 50768 2Canadian researchers set to study impact of nanomaterials on aquatic ecosystems 9112 1Canadian researchers set to study impact of nanomaterials on aquatic ecosystems 9112 2
...s, Inc., a,dental specialty pharmaceutical company...ls on the use of OraVerse (phentolamine mesylate) ...ent in the August 2008 issue of the,Journal of the...lication,entitled "Reversal of soft tissue local a...s and adults" includes an overview of two pivotal,...
...,Innovations, Inc. (Amex: IMA ), a leading provid...lth management solutions, announced today,that it ...rtment of,Agriculture (USDA) to manufacture, marke...irus Type A Antigen Test Kit. Test results are ava...ds, which can take days to,produce results., Resp...
Other Medicine Technology:Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent 2Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent 3Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit 2Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit 3
(Date:11/30/2009)... of Urology (EAU) and Europa Uomo, the European,a...ncer, have entered into an,affiliated partnership... and improve,patient awareness in Europe with reg...rs Abrahamsson, Secretary-General of the EAU: "Tha...ropa Uomo will gain access to the latest informati...
(Date:11/30/2009)...pet owner knows the enormous joy and comfort that ...s. Most pets are considered important members of t...body of research now documents the value of the hu..., mental illness, physical impairment, dementia, a...f incarcerated youth and adults. , In two articl...
(Date:11/30/2009)...Hospital has launched a series of clinical trials ...y treatment. This approach involves the applicatio...nd tumour cells from the patient him or herself an...t aggressive and frequent malignant tumours. The n...ts combined with the standard, first-line treatmen...
(Date:11/30/2009)...thor of "My Two-Year Old Eats Octopus," ...to eat everything. , (PRW... in your house? Do you find yourself acting as a ...ine videos – one focusing on packing lunches...rs for real-life parents’ questions – ...
(Date:11/30/2009)...over time, so do knees, internal injuries, study f...ws) -- If you,re a middle-age weekend warrior who ...take note: A new study suggests that high levels o...e damage that could lead to osteoarthritis. , T...e-age people who showed no symptoms and had a heal...
Breaking Medicine News(10 mins):Health News:The therapeutic benefits of the human-animal bond 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3
...y cases, when abusive parents with multiple childr... cruelty, authorities often remove the abused chil.... , But brothers and sisters of abused children c...blings, according to a study published in the curr...
... Online training programs at Penn,Foster help stud...e medical,profession today. In fact, healthcare re...ustry in the nation, even besting the massive grow...low,by 2016. Online training at Penn Foster Colleg...
..., March 5 Hundreds of,patients who rely on Commun...ion campus for medical services will be forced to ...e hospital will shut down the Pediatric and Obstet...are operations,last year., The Huntington Park ho...
... 5 Effective February, 2008, Mr.,Paul Volcker has...rd of,Directors. Mr. Volcker is well known for his...979 until 1987., In addition to Mr. Volcker,s ele... York, where he leads the firm,s,healthcare invest...
... New members of the,U.S. Preventive Services Task...M.D., director of the Agency for Healthcare Resear...d Grossman, M.D., of Seattle; J. Sanford,(Sandy) S...Ph.D., of Phoenix, joined the Task Force in Novemb...
...rs involved in a large, multi-institutional study ...ith the radiotracer fluorodeoxyglucose (FDG) were ...very high rates of success, raising hopes that dem...te various types of dementia, said Lisa Mosconi, P...
Other Medicine News:Health News:Authorities fail to recognize emotionally scarred brothers and sisters of child abuse victims 2Health News:Penn Foster Prepares Students to Meet Healthcare Employment Needs 2Health News:Penn Foster Prepares Students to Meet Healthcare Employment Needs 3Health News:Community & Mission Hospital of Huntington Park Shutting Down Mission Campus, Terminating Workers 2Health News:AHRQ Announces New Members to U.S. Preventive Services Task Force 2Health News:AHRQ Announces New Members to U.S. Preventive Services Task Force 3Health News:PET's targeted imaging may lead to earlier diagnosis of dementia and Alzheimer's disease 2Health News:PET's targeted imaging may lead to earlier diagnosis of dementia and Alzheimer's disease 3
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: